Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia (Q59624472)
Jump to navigation
Jump to search
scientific article published on 26 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia |
scientific article published on 26 June 2007 |
Statements
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia (English)
Anthony J Zagar
Mark A Deeg
Scott J Jacober
GLAI Study Investigators
Ronald B Goldberg
David M Kendall
Mehmood A Khan
Alfonzo T Perez